These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 5347672)

  • 21. Effect of intravenous propranolol on portal hypertension.
    Gupta KM; Chadda S; Chadda VS; Panwar RB; Sharda DP; Mishra SN; Chaudhary A
    J Assoc Physicians India; 1984 Apr; 32(4):343-4. PubMed ID: 6746547
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug treatment for portal hypertension due to cirrhosis].
    Lebrec D; Benhamou JP
    Gastroenterol Clin Biol; 1982; 6(6-7):542-8. PubMed ID: 6126417
    [No Abstract]   [Full Text] [Related]  

  • 23. [Functional factors which contribute to portal hypertension in hepatic cirrhosis].
    Orrego Matte H
    Medicina (B Aires); 1970; 30(4):399-401. PubMed ID: 5487697
    [No Abstract]   [Full Text] [Related]  

  • 24. [Portal hypertension in chronic liver diseases and its therapy].
    Weinreich J
    Med Monatsschr; 1969 Feb; 23(2):56-60. PubMed ID: 5801507
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medical treatment of hemorrhage in portal hypertension of the cirrhotic patient using propanolol].
    Chevrel B
    Med Chir Dig; 1982; 11(1):69-70, 73-5. PubMed ID: 6979665
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathomorphologic lesions of blood vessels in experimental pituitrin hypertension in rabbits.
    Sobis H; Szadowska A
    Arch Immunol Ther Exp (Warsz); 1967; 15(1):58-67. PubMed ID: 6048229
    [No Abstract]   [Full Text] [Related]  

  • 27. [Experimental pharmaceutical therapy of sinusoidal portal hypertension].
    Tarantino G; Mascolo G; Vitaglione R; De Rosa G
    Boll Chim Farm; 1984 Jan; 123(1):6S-15S. PubMed ID: 6721936
    [No Abstract]   [Full Text] [Related]  

  • 28. Can clamping of splenic vessels prevent abrupt increase of portal vein pressure and migration of transplanted hepatocytes to the liver after intrasplenic hepatocyte transplantation?
    Kim WH; Lee JH; Han SU; Wang HJ; Kim MW
    Hepatogastroenterology; 1998; 45(24):2425-9. PubMed ID: 9951937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between liver function and portal pressure: what comes first, the chicken or the egg?
    Triantos C; Samonakis D; Thalheimer U; Patch D; Burroughs A
    J Hepatol; 2005 Jan; 42(1):146-7; author reply 147-8. PubMed ID: 15629521
    [No Abstract]   [Full Text] [Related]  

  • 30. An appraisal and comparative study of the measurement of portal pressure by transparietal intrasplenic and intrahepatic manometries, and laparotomy.
    Silva Lde C; Goffi FS; Bastos Eda S
    Surgery; 1966 Dec; 60(6):1137-40. PubMed ID: 5926534
    [No Abstract]   [Full Text] [Related]  

  • 31. [Beta-blockers and portal hypertension].
    Rueff B
    Rev Prat; 1984 Apr; 34(19):979-80. PubMed ID: 6144165
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacological treatment of the portal hypertension].
    Castañeda Romero B
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():64-5. PubMed ID: 17471863
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
    Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
    [No Abstract]   [Full Text] [Related]  

  • 34. [Somatostatin, octreotide and portal hypertension].
    Silvain C; Besson I; Beauchant M
    Gastroenterol Clin Biol; 1994; 18(8-9):761-6. PubMed ID: 7875447
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful treatment of severe portopulmonary hypertension in a patient with Child C cirrhosis by sildenafil.
    Callejas Rubio JL; Salmerón Escobar J; González-Calvín J; Ortego Centeno N
    Liver Transpl; 2006 Apr; 12(4):690-1. PubMed ID: 16555327
    [No Abstract]   [Full Text] [Related]  

  • 36. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lessons drawn from 25 years of vasopressin use in patients with cirrhosis].
    Barbare JC; Poupon R
    Gastroenterol Clin Biol; 1984 Mar; 8(3):253-4. PubMed ID: 6609097
    [No Abstract]   [Full Text] [Related]  

  • 38. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV; Drozdov VN; Mikheeva OM; Petrakov AV
    Eksp Klin Gastroenterol; 2008; (5):37-41. PubMed ID: 19145915
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemodynamic assessment of pharmacological response in the treatment of portal hypertension: a need to know.
    Grace ND
    Am J Gastroenterol; 2000 Aug; 95(8):1862-4. PubMed ID: 10950027
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful use of continuous intravenous prostacyclin in a patient with severe portopulmonary hypertension.
    Kähler CM; Graziadei I; Wiedermann CJ; Kneussl MP; Vogel W
    Wien Klin Wochenschr; 2000 Jul; 112(14):637-40. PubMed ID: 11008327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.